FDA to reassess the safety of BHA, a preservative used in popular snack foods
The agency first listed BHA as “generally recognized as safe,” or GRAS, in 1958 and approved it as a food additive in 1961.
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
Approval will broaden the NARCAN® Nasal Spray portfolio, and improve cost-effectiveness byincreasing flexibility and distribution efficiency of ...
Pulmonology Advisor
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
Emergent BioSolutions wins FDA approval for new Narcan multipacks to expand overdose access
Emergent BioSolutions Inc. EBS stock rose Friday following the FDA approval of new multipack configurations of ...
Emergent BioSolutions Gets FDA Greenlight for Multipacks of Narcan
Emergent BioSolutions received Food and Drug Administration approval for its multipack configuration of Narcan, the opioid-overdose-reversal drug.
ARS Pharmaceuticals to Showcase Scientific Innovation and Robust Clinical Data on neffy® (epinephrine nasal spray) at 2026 American Academy of Allergy, Asthma and Immunology ...
Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...
NIH stops Johnson & Johnson's blood thinner drug arm in stroke trial after safety review (updated)
Editor’s Note: The story has been updated with comments from J&J The National Institutes of Health (NIH) on Tuesday ...